Haemodynamic effects of prenalterol in patients with coronary heart disease.

The haemodynamic effects of prenalterol, a new selective beta-1 adrenoreceptor agonist, have been studied in patients with coronary heart disease. The drug was administered intravenously in a dosage of 0.5 to 2.5 micrograms/kg body weight to 20 patients undergoing coronary angiography and to 10 pati...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Br Heart J
Principais autores:	Hutton, I, Murray, R G, Boyes, R N, Rae, A P, Hillis, W S
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Publishing Group 1980
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC482252/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6102468/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.43.2.134
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!